1932

Abstract

Cardiovascular disease (CVD) is the leading cause of death among people with severe mental disorder (SMD). CVD risk factors occur at the individual, health system, and socio-environmental levels and contribute not only to high rates of CVD but also to worsening mental health. While acknowledging this wider context, this review focuses on behavioral interventions for seven CVD risk behaviors—smoking, physical inactivity, excessive alcohol consumption, low fruit and vegetable intake, inadequate sleep, poor social participation, and poor medication adherence—that are common among people with SMD. We survey recent meta-reviews of the literature and then review additional key studies to provide clinical recommendations for behavioral interventions to reduce CVD risk among people with SMD. A transdiagnostic psychological approach from the start of mental health treatment, drawing upon multidisciplinary expertise to address multiple risk behaviors, is recommended.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-clinpsy-072720-012042
2022-05-09
2024-06-24
Loading full text...

Full text loading...

/deliver/fulltext/clinpsy/18/1/annurev-clinpsy-072720-012042.html?itemId=/content/journals/10.1146/annurev-clinpsy-072720-012042&mimeType=html&fmt=ahah

Literature Cited

  1. Albert N, Bertelsen M, Thorup A, Petersen L, Jeppesen P et al. 2011. Predictors of recovery from psychosis: analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years. Schizophr. Res. 125:257–66
    [Google Scholar]
  2. Anderson K, Laxhman N, Priebe S. 2015. Can mental health interventions change social networks? A systematic review. BMC Psychiatry 15:297
    [Google Scholar]
  3. Archibald L, Brunette MF, Wallin DJ, Green AI. 2019. Alcohol use disorder and schizophrenia or schizoaffective disorder. Alcohol Res. 40:arcr.v40.1.06
    [Google Scholar]
  4. Aust. Bureau Stat 2018. National Health Survey: first results. Australian Bureau of Statistics https://www.abs.gov.au/statistics/health/health-conditions-and-risks/national-health-survey-first-results/latest-release#data-download
    [Google Scholar]
  5. Aust. Bureau Stat 2019. Household and family projections, Australia. Australian Bureau of Statistics https://www.abs.gov.au/statistics/people/population/household-and-family-projections-australia/latest-release
    [Google Scholar]
  6. Aust. Bureau Stat 2021. Labour force, Australia. Australian Bureau of Statistics https://www.abs.gov.au/statistics/labour/employment-and-unemployment/labour-force-australia/apr-2021#employment
    [Google Scholar]
  7. Aust. Inst. Health Welf 2020. National Drug Strategy Household Survey 2019: alcohol chapter: supplementary data tables Suppl. Survey Data, Aust. Inst. Health Welf. Canberra, Aust.: https://www.aihw.gov.au/getmedia/4f178aed-4301-4d49-8fe6-c9fa663d914e/aihw-phe-270-3-Alcohol-tables.xlsx.aspx
    [Google Scholar]
  8. Aust. Inst. Health Welf 2021. Alcohol, tobacco & other drugs in Australia. Australian Institute of Health and Welfare https://www.aihw.gov.au/reports/alcohol/alcohol-tobacco-other-drugs-australia/contents/drug-types/tobacco
    [Google Scholar]
  9. Baglioni C, Nanovska S, Regen W, Spiegelhalder K, Feige B et al. 2016. Sleep and mental disorders: a meta-analysis of polysomnographic research. Psychol. Bull. 142:969–90
    [Google Scholar]
  10. Bahredar MJ, Asgharnejad Farid AA, Ghanizadeh A, Birashk B 2014. The efficacy of psycho-educational group program on medication adherence and global functioning of patients with bipolar disorder type I. Int. J. Community-Based Nurs. Midwifery 2:12–19
    [Google Scholar]
  11. Baker AL, Borland R, Bonevski B, Segan C, Turner A et al. 2019.. “ Quitlink”—a randomized controlled trial of peer worker facilitated quitline support for smokers receiving mental health services: study protocol. Front. Psychiatry 10:124
    [Google Scholar]
  12. Baker AL, Hiles SA, Thornton LK, Hides L, Lubman DI. 2012. A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders. Acta Psychiatr. Scand. 126:243–55
    [Google Scholar]
  13. Baker AL, Kay-Lambkin FJ, Richmond R, Filia S, Castle D et al. 2011. Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders. BMC Public Health 11:10
    [Google Scholar]
  14. Baker AL, Richmond R, Castle D, Kulkarni J, Kay-Lambkin F et al. 2009. Coronary heart disease risk reduction intervention among overweight smokers with a psychotic disorder: pilot trial. Aust. N.Z. J. Psychiatry 43:129–35
    [Google Scholar]
  15. Baker AL, Richmond R, Kay-Lambkin FJ, Filia SL, Castle D et al. 2015. Randomized controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders. Nicotine Tob. Res. 17:946–54
    [Google Scholar]
  16. Baker AL, Richmond R, Kay-Lambkin FJ, Filia SL, Castle D et al. 2018a. Randomised controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders: outcomes to 36months. Aust. N.Z. J. Psychiatry 52:239–52
    [Google Scholar]
  17. Baker AL, Turner A, Beck A, Berry K, Haddock G et al. 2018b. Telephone-delivered psychosocial interventions targeting key health priorities in adults with a psychotic disorder: systematic review. Psychol. Med. 48:2637–57
    [Google Scholar]
  18. Baker AL, Turner A, Kelly PJ, Spring B, Callister R et al. 2014. ‘Better Health Choices’ by telephone: a feasibility trial of improving diet and physical activity in people diagnosed with psychotic disorders. Psychiatry Res. 220:63–70
    [Google Scholar]
  19. Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L. 2013. The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia. Schizophr. Bull. 39:1242–51
    [Google Scholar]
  20. Barrowclough C, Eisner E, Bucci S, Emsley R, Wykes T 2014. The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction 109:1297–305
    [Google Scholar]
  21. Bastien CH, Vallières A, Morin CM. 2001. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2:297–307
    [Google Scholar]
  22. Bechdolf A, Köhn D, Knost B, Pukrop R, Klosterkötter J 2005. A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatr. Scand. 112:173–79
    [Google Scholar]
  23. Beebe L, Smith KD, Phillips C. 2014. A comparison of telephone and texting interventions for persons with schizophrenia spectrum disorders. Issues Ment. Health Nurs. 35:323–29
    [Google Scholar]
  24. Boniface S, Malet-Lambert I, Coleman R, Deluca P, Donoghue K et al. 2018. The effect of brief interventions for alcohol among people with comorbid mental health conditions: a systematic review of randomized trials and narrative synthesis. Alcohol Alcohol. 53:282–93
    [Google Scholar]
  25. Byerly MJ, Fisher R, Carmody T, Rush AJ. 2005. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. J. Clin. Psychiatry 66:997–1001
    [Google Scholar]
  26. Callaghan RC, Veldhuizen S, Jeysingh T, Orlan C, Graham C et al. 2014. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J. Psychiatr. Res. 48:102–10
    [Google Scholar]
  27. Castelein S, Bruggeman R, van Busschbach JT, van der Gaag M, Stant AD et al. 2008. The effectiveness of peer support groups in psychosis: a randomized controlled trial. Acta Psychiatr. Scand. 118:64–72
    [Google Scholar]
  28. Chiu VW, Ree M, Janca A, Iyyalol R, Dragovic M, Waters F 2018. Sleep profiles and CBT-I response in schizophrenia and related psychoses. Psychiatry Res. 268:279–87
    [Google Scholar]
  29. Chorlton E, Smith IC 2016. Understanding how people with mental health difficulties experience substance use. Subst. Use Misuse 51:318–29Qualitative synthesis that identifies dominant themes of substance use benefits for people with mental disorders.
    [Google Scholar]
  30. Cooper J, Mancuso SG, Borland R, Slade T, Galletly C, Castle D. 2012. Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis. Aust. N.Z. J. Psychiatry 46:851–63
    [Google Scholar]
  31. Dalcin AT, Jerome GJ, Appel LJ, Dickerson FB, Wang N-Y et al. 2019. Need for cardiovascular risk reduction in persons with serious mental illness: design of a comprehensive intervention. Front. Psychiatry 9:786
    [Google Scholar]
  32. Daumit GL, Dalcin AT, Dickerson FB, Miller ER, Evins AE et al. 2020. Effect of a comprehensive cardiovascular risk reduction intervention in persons with serious mental illness: a randomized clinical trial. JAMA Network Open 3:e207247
    [Google Scholar]
  33. Destoop M, Docx L, Morrens M, Dom G 2021. Meta-analysis on the effect of contingency management for patients with both psychotic disorders and substance use disorders. J. Clin. Med. 10:616
    [Google Scholar]
  34. Di Florio A, Craddock N, van den Bree M. 2014. Alcohol misuse in bipolar disorder. A systematic review and meta-analysis of comorbidity rates. Eur. Psychiatry 29:117–24
    [Google Scholar]
  35. Dolder CR, Lacro JP, Jeste DV. 2003. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Psychosom. Med. 65:156–62
    [Google Scholar]
  36. DPP (Diabetes Prev. Program) Res. Group 2002. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 25:2165–71
    [Google Scholar]
  37. Firth J, Siddiqi N, Koyanagi A, Siskind D, Rosenbaum S et al. 2019. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry 6:675–712
    [Google Scholar]
  38. Firth J, Solmi M, Wootton RE, Vancampfort D, Schuch FB et al. 2020. A meta-review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders. World Psychiatry 19:360–80
    [Google Scholar]
  39. Foley DL, Mackinnon A, Morgan VA, Watts GF, McGrath JJ et al. 2014. Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis. World Psychiatry 13:176–83
    [Google Scholar]
  40. Frangou S, Sachpazidis I, Stassinakis A, Sakas G 2005. Telemonitoring of medication adherence in patients with schizophrenia. Telemed. e-Health 11:675–83
    [Google Scholar]
  41. Freeman D, Waite F, Startup H, Myers E, Lister R et al. 2015. Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial. Lancet Psychiatry 2:975–83
    [Google Scholar]
  42. Gianfrancesco FD, Sajatovic M, Rajagopalan K, Wang RH 2008. Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder. Clin. Ther. 30:1358–74
    [Google Scholar]
  43. Graham HL, Copello A, Griffith E, Clarke L, Walsh K et al. 2019. Mental health hospital admissions: a teachable moment and window of opportunity to promote change in drug and alcohol misuse. Int. J. Ment. Health Addict. 17:22–40
    [Google Scholar]
  44. Gray R, Leese M, Bindman J, Becker T, Burti L et al. 2006. Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial. Br. J. Psychiatry 189:508–14
    [Google Scholar]
  45. Hahn LA, Galletly CA, Foley DL, Mackinnon A, Watts GF et al. 2014. Inadequate fruit and vegetable intake in people with psychosis. Aust. N.Z. J. Psychiatry 48:1025–35
    [Google Scholar]
  46. Hamann J, Cohen R, Leucht S, Busch R, Kissling W. 2007. Shared decision making and long-term outcome in schizophrenia treatment. J. Clin. Psychiatry 68:992–97
    [Google Scholar]
  47. Hartung D, Low A, Jindai K, Mansoor D, Judge M et al. 2017. Interventions to improve pharmacological adherence among adults with psychotic spectrum disorders and bipolar disorder: a systematic review. Psychosomatics 58:101–12
    [Google Scholar]
  48. Harvey CA, Jeffreys SE, McNaught AS, Blizard RA, King MB. 2007. The Camden Schizophrenia Surveys III: five-year outcome of a sample of individuals from a prevalence survey and the importance of social relationships. Int. J. Soc. Psychiatry 53:340–56
    [Google Scholar]
  49. Hasson-Ohayon I, Mashiach-Eizenberg M, Avidan M, Roberts DL, Roe D. 2014. Social cognition and interaction training: preliminary results of an RCT in a community setting in Israel. Psychiatr. Serv. 65:555–58
    [Google Scholar]
  50. Heather N 2017. Overview of addiction as a disorder of choice and future prospects. Addiction and Choice: Rethinking the Relationship N Heather, G Segal 463–82 Oxford, UK: Oxford Univ. Press
    [Google Scholar]
  51. Hippisley-Cox J, Parker C, Coupland C, Vinogradova Y 2007. Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: a cross-sectional study. Heart 93:1256–62
    [Google Scholar]
  52. Hovhannisyan K, Rasmussen M, Adami J, Wikström M, Tønnesen H 2020. Evaluation of Very Integrated Program: health promotion for patients with alcohol and drug addiction—a randomized trial. Alcohol. Clin. Exp. Res. 44:1456–67
    [Google Scholar]
  53. Hunt GE, Siegfried N, Morley K, Brooke-Sumner C, Cleary M. 2019. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD001088.pub4
    [Crossref] [Google Scholar]
  54. Hwang D-K, Nam M, Lee Y-JG 2019. The effect of cognitive behavioral therapy for insomnia in schizophrenia patients with sleep disturbance: a non-randomized, assessor-blind trial. Psychiatry Res. 274:182–88
    [Google Scholar]
  55. Javadpour A, Hedayati A, Dehbozorgi GR, Azizi A. 2013. The impact of a simple individual psycho-education program on quality of life, rate of relapse and medication adherence in bipolar disorder patients. Asian J. Psychiatry 6:208–13
    [Google Scholar]
  56. Jayatilleke N, Hayes RD, Dutta R, Shetty H, Hotopf M et al. 2017. Contributions of specific causes of death to lost life expectancy in severe mental illness. Eur. Psychiatry 43:109–15
    [Google Scholar]
  57. Jørgensen KB, Nordentoft M, Hjorthøj C. 2018. Association between alcohol and substance use disorders and psychiatric service use in patients with severe mental illness: a nationwide Danish register-based cohort study. Psychol. Med. 48:2592–600
    [Google Scholar]
  58. Kavanagh K, Duncan-Macconnell D, Greenwood K, Trivedi P, Wykes TIL. 2003. Educating acute inpatients about their medication: Is it worth it? An exploratory study of group education for patients on a psychiatric intensive care unit. J. Ment. Health 12:71–80
    [Google Scholar]
  59. Kemp R, Kirov G, Everitt B, Hayward P, David A 1998. Randomised controlled trial of compliance therapy: 18-month follow-up. Br. J. Psychiatry 172:413–19
    [Google Scholar]
  60. Khaw K-T, Wareham N, Bingham S, Welch A, Luben R, Day N 2008. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLOS Med. 5:e12
    [Google Scholar]
  61. Kikkert M, Goudriaan A, de Waal M, Peen J, Dekker J 2018. Effectiveness of integrated dual diagnosis treatment (IDDT) in severe mental illness outpatients with a co-occurring substance use disorder. J. Subst. Abuse Treat. 95:35–42
    [Google Scholar]
  62. Kopelowicz A, Zarate R, Wallace CJ, Liberman RP, Lopez SR, Mintz J. 2012. The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia. Arch. Gen. Psychiatry 69:265–73
    [Google Scholar]
  63. Koskinen J, Löhönen J, Koponen H, Isohanni M, Miettunen J. 2009. Prevalence of alcohol use disorders in schizophrenia—a systematic review and meta-analysis. Acta Psychiatr. Scand. 120:85–96
    [Google Scholar]
  64. Krokstad S, Ding D, Grunseit AC, Sund ER, Holmen TL et al. 2017. Multiple lifestyle behaviours and mortality, findings from a large population-based Norwegian cohort study—the HUNT Study. BMC Public Health 17:58
    [Google Scholar]
  65. Lee S-H, Choi TK, Suh S, Kim YW, Kim B et al. 2010. Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection. Psychiatry Res. 175:195–99
    [Google Scholar]
  66. Liu NH, Daumit GL, Dua T, Aquila R, Charlson F et al. 2017. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry 16:30–40
    [Google Scholar]
  67. McClave AK, McKnight-Eily LR, Davis SP, Dube SR 2010. Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. Am. J. Public Health 100:2464–72
    [Google Scholar]
  68. Montes JM, Medina E, Gomez-Beneyto M, Maurino J. 2012. A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia. Psychiatry Res. 200:89–95
    [Google Scholar]
  69. Moore E, Mancuso SG, Slade T, Galletly C, Castle DJ. 2012. The impact of alcohol and illicit drugs on people with psychosis: the second Australian national survey of psychosis. Aust. N.Z. J. Psychiatry 46:864–78
    [Google Scholar]
  70. Morgan VA, Waterreus A, Carr V, Castle D, Cohen M et al. 2017. Responding to challenges for people with psychotic illness: updated evidence from the Survey of High Impact Psychosis. Aust. N.Z. J. Psychiatry 51:124–40
    [Google Scholar]
  71. Moritz S, Peters MJ, Karow A, Deljkovic A, Tonn P, Naber D. 2009. Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients. Ment. Illn. 1:e2
    [Google Scholar]
  72. Mueser KT, Gingerich S. 2013. Treatment of co-occurring psychotic and substance use disorders. Soc. Work Public Health 28:424–39
    [Google Scholar]
  73. Mullin K, Gupta P, Compton MT, Nielssen O, Harris A, Large M 2012. Does giving up substance use work for patients with psychosis? A systematic meta-analysis. Aust. N.Z. J. Psychiatry 46:826–39
    [Google Scholar]
  74. Murphy KA, Daumit GL, Stone E, McGinty EE. 2018. Physical health outcomes and implementation of behavioural health homes: a comprehensive review. Int. Rev. Psychiatry 30:224–41
    [Google Scholar]
  75. Natl. Health Med. Res. Council 2013. Australian Dietary Guidelines Canberra, Aust.: Natl. Health Med. Res. Council
    [Google Scholar]
  76. Ng TH, Chung KF, Ho FY, Yeung WF, Yung KP, Lam TH 2015. Sleep-wake disturbance in interepisode bipolar disorder and high-risk individuals: a systematic review and meta-analysis. Sleep Med. Rev. 20:46–58
    [Google Scholar]
  77. NICE (Natl. Inst. Health Care Excell.) 2016. Coexisting severe mental illness and substance misuse: community health and social care services Guideline NG58, NICE London: https://www.nice.org.uk/guidance/ng58 Comprehensive clinical guidelines for clients and clinicians working with people with substance use and severe mental disorder.
    [Google Scholar]
  78. Nielsen RE, Banner J, Jensen SE. 2021. Cardiovascular disease in patients with severe mental illness. Nat. Rev. Cardiol. 18:136–45
    [Google Scholar]
  79. Nordentoft M, Wahlbeck K, Hällgren J, Westman J, Ösby U et al. 2013. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLOS ONE 8:e55176
    [Google Scholar]
  80. O'Donnell C, Donohoe G, Sharkey L, Owens N, Migone M et al. 2003. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ 327:834
    [Google Scholar]
  81. Ouellet-Plamondon C, Abdel-Baki A, Salvat É, Potvin S 2017. Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes. Psychol. Med. 47:2461–71
    [Google Scholar]
  82. Piette JD, Heisler M, Ganoczy D, McCarthy JF, Valenstein M. 2007. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension. Psychiatr. Serv. 58:207–12
    [Google Scholar]
  83. Pitkänen A, Hätönen H, Kuosmanen L, Välimäki M 2009. Individual quality of life of people with severe mental disorders. J. Psychiatr. Ment. Health Nurs. 16:3–9
    [Google Scholar]
  84. Pitschel-Walz G, Bäuml J, Bender W, Engel RR, Wagner M, Kissling W. 2006. Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich psychosis information project study. J. Clin. Psychiatry 67:443–52
    [Google Scholar]
  85. R. Aust. N.Z. Coll. Psychiatr 2016. The economic cost of serious mental illness and comorbidities in Australia and New Zealand Rep., R. Aust. N.Z. Coll. Psychiatr. Melbourne, Aust:.
    [Google Scholar]
  86. Ruggeri M, Leese M, Thornicroft G, Bisoffi G, Tansella M. 2000. Definition and prevalence of severe and persistent mental illness. Br. J. Psychiatry 177:149–55
    [Google Scholar]
  87. Sajatovic M, Davies MA, Ganocy SJ, Bauer MS, Cassidy KA et al. 2009. A comparison of the life goals program and treatment as usual for individuals with bipolar disorder. Psychiatr. Serv. 60:1182–89
    [Google Scholar]
  88. Sajatovic M, Levin J, Ramirez LF, Hahn DY, Tatsuoka C et al. 2013. Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder. J. Clin. Psychiatry 74:1249–55
    [Google Scholar]
  89. Sajatovic M, Levin J, Tatsuoka C, Micula-Gondek W, Fuentes-Casiano E et al. 2012. Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder. Bipolar Disord. 14:291–300
    [Google Scholar]
  90. Schulz M, Gray R, Spiekermann A, Abderhalden C, Behrens J, Driessen M. 2013. Adherence therapy following an acute episode of schizophrenia: a multi-centre randomised controlled trial. Schizophr. Res. 146:59–63
    [Google Scholar]
  91. Segan CJ, Baker AL, Turner A, Williams JM 2017. Nicotine withdrawal, relapse of mental illness, or medication side-effect? Implementing a monitoring tool for people with mental illness into quitline counseling. J. Dual Diagn. 13:60–66Provides a monitoring tool to assist clients in preparation for and during smoking cessation.
    [Google Scholar]
  92. Sheaves B, Freeman D, Isham L, McInerney J, Nickless A et al. 2018. Stabilising sleep for patients admitted at acute crisis to a psychiatric hospital (OWLS): an assessor-blind pilot randomised controlled trial. Psychol. Med. 48:1694–704
    [Google Scholar]
  93. Sheaves B, Holmes EA, Rek S, Taylor KM, Nickless A et al. 2019. Cognitive behavioural therapy for nightmares for patients with persecutory delusions (Nites): an assessor-blind, pilot randomized controlled trial. Can. J. Psychiatry 64:686–96
    [Google Scholar]
  94. Sheridan AJ, Drennan J, Coughlan B, O'Keeffe D, Frazer K et al. 2015. Improving social functioning and reducing social isolation and loneliness among people with enduring mental illness: report of a randomised controlled trial of supported socialisation. Int. J. Soc. Psychiatry 61:241–50
    [Google Scholar]
  95. Skarsholm H, Stoevring H, Nielsen B. 2014. Effect of a system-oriented intervention on compliance problems in schizophrenia: a pragmatic controlled trial. Schizophr. Res. Treat. 2014:789403
    [Google Scholar]
  96. Speyer H, Jakobsen AS, Westergaard C, Nørgaard HCB, Jørgensen KB et al. 2019. Lifestyle interventions for weight management in people with serious mental illness: a systematic review with meta-analysis, trial sequential analysis, and meta-regression analysis exploring the mediators and moderators of treatment effects. Psychother. Psychosom. 88:350–62
    [Google Scholar]
  97. Stain HJ, Galletly CA, Clark S, Wilson J, Killen EA et al. 2012. Understanding the social costs of psychosis: the experience of adults affected by psychosis identified within the second Australian National Survey of Psychosis. Aust. N.Z. J. Psychiatry 46:879–89
    [Google Scholar]
  98. Stubbs B, Williams J, Gaughran F, Craig T 2016. How sedentary are people with psychosis? A systematic review and meta-analysis. Schizophr. Res. 171:103–9
    [Google Scholar]
  99. Talley RM, Brunette MF, Adler DA, Dixon LB, Berlant J et al. 2021. Telehealth and the community SMI population: reflections on the disrupter experience of COVID-19. J. Nerv. Ment. Dis. 209:49–53
    [Google Scholar]
  100. Terzian E, Tognoni G, Bracco R, De Ruggieri E, Ficociello RA et al. 2013. Social network intervention in patients with schizophrenia and marked social withdrawal: a randomized controlled study. Can. J. Psychiatry 58:622–31
    [Google Scholar]
  101. Thomas N, Foley F, Lindblom K, Lee S 2017. Are people with severe mental illness ready for online interventions? Access and use of the Internet in Australian mental health service users. Australas. Psychiatry 25:257–61
    [Google Scholar]
  102. Valencia M, Rascon ML, Juarez F, Escamilla R, Saracco R, Liberman RP. 2010. Application in Mexico of psychosocial rehabilitation with schizophrenia patients. Psychiatry 73:248–63
    [Google Scholar]
  103. Valtorta NK, Kanaan M, Gilbody S, Ronzi S, Hanratty B 2016. Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies. Heart 102:1009–16
    [Google Scholar]
  104. Vancampfort D, Firth J, Schuch FB, Rosenbaum S, Mugisha J et al. 2017. Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis. World Psychiatry 16:308–15
    [Google Scholar]
  105. Velligan D, Mintz J, Maples N, Xueying L, Gajewski S et al. 2012. A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophrenia. Schizophr. Bull. 39:999–1007
    [Google Scholar]
  106. Villalta-Gil V, Roca M, Gonzalez N, Domènec E, Cuca et al. 2009. Dog-assisted therapy in the treatment of chronic schizophrenia inpatients. Anthrozoös 22:149–59
    [Google Scholar]
  107. Waite F, Sheaves B, Isham L, Reeve S, Freeman D 2020. Sleep and schizophrenia: from epiphenomenon to treatable causal target. Schizophr. Res. 221:44–56
    [Google Scholar]
  108. Walker ER, McGee RE, Druss BG. 2015. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 72:334–41
    [Google Scholar]
  109. Ward MC, White DT, Druss BG. 2015. A meta-review of lifestyle interventions for cardiovascular risk factors in the general medical population: lessons for individuals with serious mental illness. J. Clin. Psychiatry 76:e477–86
    [Google Scholar]
  110. WHO (World Health Organ.) 2013. Comprehensive mental health action plan 2013–2020 Action plan, WHO Geneva:
    [Google Scholar]
  111. Zabeen S, Phua D, Mohammadi L, Lawn S 2020. Family involvement to support cardiovascular self-management care for people with severe mental illness: a systematic review. J. Ment. Health. https://doi.org/10.1080/09638237.2020.1818194
    [Crossref] [Google Scholar]
/content/journals/10.1146/annurev-clinpsy-072720-012042
Loading
/content/journals/10.1146/annurev-clinpsy-072720-012042
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error